These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6891766)

  • 1. Coats' disease. Evaluation of management.
    Ridley ME; Shields JA; Brown GC; Tasman W
    Ophthalmology; 1982 Dec; 89(12):1381-7. PubMed ID: 6891766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of moderate to advanced Coats' disease.
    Kiratli H; Eldem B
    Ophthalmologica; 1998; 212(1):19-22. PubMed ID: 9438579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the management of Coats' disease: less is more.
    Adam RS; Kertes PJ; Lam WC
    Br J Ophthalmol; 2007 Mar; 91(3):303-6. PubMed ID: 17020897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and management of Coats disease: the 2000 Proctor Lecture.
    Shields JA; Shields CL; Honavar SG; Demirci H; Cater J
    Am J Ophthalmol; 2001 May; 131(5):572-83. PubMed ID: 11336931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history and management of advanced Coats' disease.
    Silodor SW; Augsburger JJ; Shields JA; Tasman W
    Ophthalmic Surg; 1988 Feb; 19(2):89-93. PubMed ID: 3347463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual prognosis of Coats' disease.
    Budning AS; Heon E; Gallie BL
    J AAPOS; 1998 Dec; 2(6):356-9. PubMed ID: 10532724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective photocoagulation in Coats' disease: ten-year follow-up.
    Nucci P; Bandello F; Serafino M; Wilson ME
    Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
    Li S; Deng G; Liu J; Ma Y; Lu H
    BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation.
    Cahill M; O'Keefe M; Acheson R; Mulvihill A; Wallace D; Mooney D
    Acta Ophthalmol Scand; 2001 Dec; 79(6):596-602. PubMed ID: 11782226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.
    Yousef YA; ElRimawi AH; Nazzal RM; Qaroot AF; AlAref AH; Mohammad M; Abureesh O; Rejdak R; Nowomiejska K; Avitabile T; Toro MD; AlNawaiseh I
    Medicine (Baltimore); 2020 Apr; 99(16):e19623. PubMed ID: 32311932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.
    Shields JA; Shields CL; Honavar SG; Demirci H
    Am J Ophthalmol; 2001 May; 131(5):561-71. PubMed ID: 11336930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.
    Cai X; Zhao P; Zhang Q; Jin H
    Graefes Arch Clin Exp Ophthalmol; 2015 Jul; 253(7):999-1004. PubMed ID: 25794987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitrectomy techniques in late-stage Coats'-like exudative retinal detachment.
    Yoshizumi MO; Kreiger AE; Lewis H; Foxman B; Hakakha BA
    Doc Ophthalmol; 1995; 90(4):387-94. PubMed ID: 8620821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF COATS DISEASE IN A SAUDI ARABIAN POPULATION.
    Al-Qahtani AA; Almasaud JM; Ghazi NG
    Retina; 2015 Oct; 35(10):2091-9. PubMed ID: 25978728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of retinal detachment in Coats' disease].
    Berzas C; Richard G
    Fortschr Ophthalmol; 1991; 88(6):598-602. PubMed ID: 1794774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Scleral Buckling, Transscleral Drainage of Subretinal Fluid, Intravitreal Anti-Vascular Endothelial Growth Factor, and Laser Photocoagulation in Stage 3B Coats' Total Retinal Detachment.
    Huang YC; Lai CC; Wu WC
    Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):865-8. PubMed ID: 27631484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitrectomy for severe Coats' disease].
    Jiang R; Chen Q; Wang W
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):87-9. PubMed ID: 11955307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma.
    Baumal CR; Shields CL; Shields JA; Tasman WS
    Ophthalmology; 1998 Nov; 105(11):2134-9. PubMed ID: 9818618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.